WHOLE SHINE MEDICAL: Receives enforcement notice, enforcement target 217 million yuan

Source: Haochen Medical's announcement regarding receipt of the "Notice of Enforcement"

DentalGoodNews｜On September 30, 2026, WHOLE SHINE MEDICAL TECHNOLOGY CO.,LTD. (hereinafter referred to as "WHOLE SHINE MEDICAL") issued an announcement stating that the company recently received the (2026) Jing 01 Zhi Hui No. 669 "Notice of Execution" and "Order to Report Property" served by the Beijing First Intermediate People's Court.

According to the announcement, the subject matter of this execution is RMB 216,847,760.42 (approximately RMB 217 million), which originates from a loan contract dispute signed between the company and Bank of Wenzhou in 2020. As of the date of the announcement, the company still owes loan principal of RMB 95,741,435.88 (approximately RMB 95.7414 million). It is reported that this creditor's right has undergone multiple transfers, and the current creditor is Zhejiang Zhebai Xiannvhu Enterprise Management Partnership (Limited Partnership).

Previously, due to unfulfilled debts, the bank accounts, factory buildings, and equity in Zhiyu Medical held by WHOLE SHINE MEDICAL and its subsidiary Yongda Electric have been successively seized and frozen by courts, during which RMB 4,148,564.12 (approximately RMB 4.1486 million) was judicially transferred. According to previous reports by DGN, another contract dispute case involving WHOLE SHINE MEDICAL has entered the stage of resumed execution, with a subject matter of RMB 361,220,497.02 (approximately RMB 361 million). The company has accrued estimated liabilities of RMB 215.2733 million (approximately RMB 215 million) in the 2022 fiscal year, and has accrued current interest payable on a yearly basis since the 2023 fiscal year.

WHOLE SHINE MEDICAL currently primarily carries out Oral medical services through its controlling subsidiary Guangdong Delun Medical Group Co., Ltd. The company stated that it still faces the risk of further judicial freezing of assets, which may affect its production and operations.

Source: Haochen Medical's 2026 Semi-Annual Report

According to previous reports by DGN, WHOLE SHINE MEDICAL achieved operating revenue of RMB 314 million in the first half of 2026, basically flat compared with the same period last year (a year-on-year increase of 0.14%); the net profit attributable to shareholders of the listed company was -RMB 14.0259 million, narrowing the loss by 40.95% from -RMB 23.7511 million in the same period last year.

During the reporting period, WHOLE SHINE MEDICAL's Oral medical service business achieved revenue of RMB 296 million, a year-on-year increase of 2.43%, accounting for 94.09% of total revenue; the Gross Margin was 53.49%, up 9.88% from the same period last year. The company's core subsidiary Delun Medical achieved operating revenue of RMB 296 million in the first half of the year, a year-on-year increase of 2.43%, and net profit of RMB 18.0438 million, an increase of RMB 37.9348 million from -RMB 19.8910 million in the same period last year, achieving a turnaround from loss to profit.